Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors

• Published in: Cancer cell international Vol. 24; no. 1; pp. 122 - 12
• Main Authors: Liao, Bing, Wang, Jialing, Yuan, Yalin, Luo, Hongliang, Ouyang, Xi
• Format: Journal Article
• Language: English
• Published: England BioMed Central 30.03.2024; BMC
• Subjects: Apoptosis; Biomarkers; Brain cancer; Cancer biomarker; Cancer therapies; Cell cycle; Cell growth; CRISPR; Disease; Ferroptosis; Gene expression; Glioma; Human tumor; Kidney cancer; Liver cancer; Medical prognosis; Medical research; Metabolism; MicroRNAs; Review; Roles; SLC16A1-AS1; Squamous cell carcinoma; Therapeutic targets; Tumor suppressor genes; Tumorigenesis; Tumors; Cancer biomarker; SLC16A1-AS1; Tumorigenesis; Human tumor

Recent studies have increasingly highlighted the aberrant expression of SLC16A1-AS1 in a variety of tumor types, where it functions as either an oncogene or a tumor suppressor in the pathogenesis of different cancers. The expression levels of SLC16A1-AS1 have been found to significantly correlate wi...